Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 10,016,498 | 07/10/2018 | 2013-041 |
Peptidoglycan (PG) is an essential component of the bacterial cell wall. Although experiments with model organisms in vitro have yielded a wealth of information on PG synthesis and maturation, it is unclear how these studies translate to pathogenic bacteria replicating within host cells. Because PG is required for bacterial viability and absent from eukaryotic cells, it has proven an excellent antibiotic target. Despite its medical importance, there is little known about PG metabolism in the host environment. Investigation of PG in this context has the potential to reveal novel routes of inhibition. Although biochemical methods have revealed PG dynamics in the context of whole bacterial cells, these techniques suffer from limited species applicability, technical complexity or low resolution.
Scientists at UC Berkeley have developed a chemical approach for probing PG in vivo via metabolic labeling and bioorthogonal chemistry. A wide variety of bacterial species incorporated azide and alkyne-functionalized D-alanine into their cell walls, which can be visualized by covalent reaction with click chemistry probes. The D-alanine analogs were specifically incorporated into nascent PG of the intracellular pathogen Listeria monocytogenes both in vitro and during macrophage infection. Metabolic incorporation of D-alanine derivatives and click chemistry detection constitute a facile, modular platform that facilitates unprecedented spatial and temporal resolution of PG dynamics in vivo.